Gulf International Bank (UK)’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,200
Closed -$970K 697
2022
Q3
$970K Hold
7,200
0.02% 570
2022
Q2
$1.17M Hold
7,200
0.02% 561
2022
Q1
$1.36M Hold
7,200
0.02% 558
2021
Q4
$1.95M Buy
7,200
+1,200
+20% +$405K 0.03% 511
2021
Q3
$2.18M Hold
6,000
0.03% 528
2021
Q2
$2.06M Hold
6,000
0.03% 554
2021
Q1
$2.09M Hold
6,000
0.03% 531
2020
Q4
$1.55M Sell
6,000
-3,900
-39% -$1.07M 0.02% 606
2020
Q3
$2.83M Buy
9,900
+1,000
+11% +$235K 0.04% 410
2020
Q2
$1.68M Hold
8,900
0.03% 522
2020
Q1
$1.09M Hold
8,900
0.02% 539
2019
Q4
$1.48M Hold
8,900
0.02% 568
2019
Q3
$1.09M Hold
8,900
0.02% 586
2019
Q2
$1.1M Hold
8,900
0.02% 598
2019
Q1
$1.17M Hold
8,900
0.02% 574
2018
Q4
$1.25M Buy
+8,900
New +$1.18M 0.02% 543

Other funds holding ONC

Gulf International Bank (UK)'s ONC Position: Q4 2022 in Review

Gulf International Bank (UK) sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 7,200 shares — an estimated $970K sold.

Gulf International Bank (UK) first reported a position in ONC in Q4 2018 and held it in 16 quarters. The position peaked at $2.83M in Q3 2020. 214 funds tracked by Wall St. Rank hold ONC as of Q4 2022.

  • Gulf International Bank (UK) reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
  • Gulf International Bank (UK) sold 7,200 BeOne Medicines Ltd shares in Q4 2022, an estimated $970K.
  • Gulf International Bank (UK) first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 16 quarters.
  • Gulf International Bank (UK)'s BeOne Medicines Ltd position peaked at $2.83M in Q3 2020.
  • 214 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.

Based on Gulf International Bank (UK)'s 13F filing for Q4 2022, filed 8 Feb 2023.